We acknowledge that the UBC Vancouver campus is situated on the traditional, ancestral, and unceded territory of the xʷməθkʷəy̓əm (Musqueam).
Through gifts made to InnerChange Foundation, which provides leadership, funding and advocacy to improve the health outcomes for people who are suffering from mental health challenges and addiction, these donors are supporting improvements in treatment options for chronic heroin addiction.
The only clinical trial of its kind in North America, SALOME is testing whether hydromorphone (Dilaudid®), a licensed pain medication, is as effective as diacetylmorphine, the active ingredient of heroin, at engaging the most vulnerable long-term street heroin users, so they will enroll in treatment programs and end their use of illicit drugs.